Two novel DNMT1 inhibitors: 4′-Thio-2′-Deoxycytidine and 5’-aza-4′-Thio-2′-Deoxycytidine, for the treatment of MEN1 tumors in preclinical study.
Home » Two novel DNMT1 inhibitors: 4′-Thio-2′-Deoxycytidine and 5’-aza-4′-Thio-2′-Deoxycytidine, for the treatment of MEN1 tumors in preclinical study.
Two novel DNMT1 inhibitors: 4′-Thio-2′-Deoxycytidine and 5’-aza-4′-Thio-2′-Deoxycytidine, for the treatment of MEN1 tumors in preclinical study.
